Market View

The U.S. market remains in a Rally Attempt. The S&P 500 and Nasdaq have regained and are consolidating above 50-DMA
support (5,139/16,085). In addition, both indices are only 1% off all-time highs ( 5,264/16,538). We will shift the market status to a
Confirmed Uptrend either on a follow-through day (+1.7% on volume higher d/d) or on a close at a new all-time high.

O’Neil Health Care Weekly

XLV gained 62 bps last week, trading relatively flat for the third consecutive week and directly at its 21-DMA ($141). Resistance
remains the 100-DMA ($141.70), followed by the rolling 50-DMA ($143.43). Support is at its 200-DMA ($136). Its RS line (vs. the S&P
500 and Nasdaq) continues to trade near lows warranting an underweight sector positioning.

Market View

The U.S. market remains in a Rally Attempt. On Friday, the Nasdaq narrowly missed a day-10 follow-through day, rising 2.0% on volume that was slightly below the prior day. The S&P 500 did also rose 1.3% on Friday on lower volume. For the week, indices were up 0.5% and 1.4%, respectively. The S&P 500 is testing its 50-DMA (5,130) after trading below for three weeks. The Nasdaq retook the 50-DMA (16,058) and is back to within 2% of all-time highs after trading as much as 8% off highs.

O’Neil Health Care Weekly

XLV traded relatively flat for a second straight week, still finding resistance at its 21- and 100-DMA ($141.19), as 200-DMA ($136.10)
support steadily rises. Its RS line (vs. the S&P 500 and Nasdaq) remains in a downtrend, still warranting an underweight sector
positioning.

Market View

The U.S. market remains in a Rally Attempt. Indices have rallied off recent lows (S&P 500: 4,953; Nasdaq: 15,222) as the Nasdaq narrowly missed a follow-day after a strong move on Friday. Both indices face resistance at the at their respective 50-DMAs (S&P 500: 5,124; Nasdaq: 16,052).

 

Over the last five sessions, Technology and Consumer Cyclical rose ~4% and outperformed, followed by Retail, jumping 2%. Four other sectors – Consumer Staple, Energy, Capital Equipment and Utility – rose 1%, while Financial, Health Care and Basic Material gained slightly less than 1%. The best performing industry groups over the past five sessions include Department Stores, Auto Manufacturers, Ships, Banks, Leisure Toys, Education, Hospitals and Semiconductor Manufacturing. The worst performing industry groups over the past five sessions include Hardware, Steel, Leisure Movies, Wholesale Food, Internet Content, Auto Parts, Machinery, Specialty Retail and Solar. Forty-five percent of S&P 500 stocks are trading above their 50-DMA, and 72% are trading above their 200-DMA versus 34% and 67%, respectively, a week ago. Thirty-three percent of Nasdaq 100 stocks are trading above their respective 50-DMA, versus 18% one week ago.

O’Neil Health Care Weekly

XLV traded relatively flat last week following a 6% decline in the previous two weeks. Though the sector remains near-term oversold, it
now faces multiple levels of resistance including its 100-DMA ($140.71). The next level of support is the 200-DMA ($135.84). Its RS
line (vs. the S&P 500 and Nasdaq) picked up slightly last week but still warrants an underweight sector positioning given few stocks
are in position to buy.

Market View

The U.S. market is in a Downtrend. On Monday, we shifted the market to a Downtrend for the first time since late-October 2023. For the week, the S&P 500 and the Nasdaq fell 3.0% and 5.5%, respectively, and each breached their 50-DMA for the first time in over five months. The Nasdaq also sliced below the 100-DMA (15,490), while the S&P 500 remains slightly above (4,935). Long-term 200-DMA support is 6% and 4% below, respectively. With another low set on Friday, we need to see four days off the bottom before a potential follow-through day, which could now occur next Thursday at the earliest.

O’Neil Health Care Weekly

XLV declined another 3% last week, closing below its 100-DMA ($140.26) which may now act as near-term resistance. Though we
believe the sector is short-term oversold, it is more likely to chop in a range with the next level of support at ~$136.50, which may
coincide with a rising 200-DMA ($135.66). We continue to recommend an underweight sector positioning given its RS line continues
to fall to new lows.

Market View

The U.S. market remains in an Uptrend Under Pressure. Price action remains very volatile as both indices pulled back and are testing their respective 50-DMAs (S&P 500: 5,111, Nasdaq: 16,061). Should both indices close below their 50-DMA, the market status is at risk of being downgraded to Correction. Currently the distribution day count stands at seven and six days on the S&P 500 and Nasdaq, respectively, with two days expiring on each index at the end of next week.

O’Neil Health Care Weekly

XLV was the second worst performing sector (Retail) last week, falling over 3% and breaking 50-DMA support ($144.71) which will
now act as near-term resistance. The next support level is the rising 100-DMA ($139.56). XLV’s RS line (vs. the S&P 500 and Nasdaq)
made a lower low, warranting an underweight sector positioning.